These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 29376471)

  • 1. Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization.
    Xu L; Ota T
    Adipocyte; 2018; 7(2):121-128. PubMed ID: 29376471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
    Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
    EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet.
    Xu L; Nagata N; Chen G; Nagashimada M; Zhuge F; Ni Y; Sakai Y; Kaneko S; Ota T
    BMJ Open Diabetes Res Care; 2019; 7(1):e000783. PubMed ID: 31749970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice.
    Nagata N; Xu L; Kohno S; Ushida Y; Aoki Y; Umeda R; Fuke N; Zhuge F; Ni Y; Nagashimada M; Takahashi C; Suganuma H; Kaneko S; Ota T
    Diabetes; 2017 May; 66(5):1222-1236. PubMed ID: 28209760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
    PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.
    Zhang M; Zhou Z; Wang J; Li S
    Immunol Lett; 2016 Dec; 180():1-8. PubMed ID: 27746169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice.
    Tahara A; Takasu T
    Endocr Res; 2020; 45(2):147-161. PubMed ID: 31955626
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium glucose cotransporter 2 inhibitor dapagliflozin depressed adiposity and ameliorated hepatic steatosis in high-fat diet induced obese mice.
    Han T; Fan Y; Gao J; Fatima M; Zhang Y; Ding Y; Bai L; Wang C
    Adipocyte; 2021 Dec; 10(1):446-455. PubMed ID: 34550043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine, a Traditional Chinese Medicine, Reduces Inflammation in Adipose Tissue, Polarizes M2 Macrophages, and Increases Energy Expenditure in Mice Fed a High-Fat Diet.
    Lin J; Cai Q; Liang B; Wu L; Zhuang Y; He Y; Lin W
    Med Sci Monit; 2019 Jan; 25():87-97. PubMed ID: 30606998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice.
    Chen YS; Liu HM; Lee TY
    Cells; 2019 Mar; 8(3):. PubMed ID: 30884843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity.
    Xiong XQ; Geng Z; Zhou B; Zhang F; Han Y; Zhou YB; Wang JJ; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
    Metabolism; 2018 Jun; 83():31-41. PubMed ID: 29374559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance.
    Xu L; Nagata N; Ota T
    Adipocyte; 2018; 7(3):218-225. PubMed ID: 29898626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity.
    Yasui M; Tamura Y; Minami M; Higuchi S; Fujikawa R; Ikedo T; Nagata M; Arai H; Murayama T; Yokode M
    PLoS One; 2015; 10(8):e0136304. PubMed ID: 26308623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Browning of white fat: agents and implications for beige adipose tissue to type 2 diabetes.
    Kaisanlahti A; Glumoff T
    J Physiol Biochem; 2019 Feb; 75(1):1-10. PubMed ID: 30506389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canagliflozin ameliorates hepatic fat deposition in obese diabetic mice: Role of prostaglandin E
    Yoshino K; Hosooka T; Shinohara M; Aoki C; Hosokawa Y; Imamori M; Ogawa W
    Biochem Biophys Res Commun; 2021 Jun; 557():62-68. PubMed ID: 33862461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats.
    Aragón-Herrera A; Moraña-Fernández S; Otero-Santiago M; Anido-Varela L; Campos-Toimil M; García-Seara J; Román A; Seijas J; García-Caballero L; Rodríguez J; Tarazón E; Roselló-Lletí E; Portolés M; Lage R; Gualillo O; González-Juanatey JR; Feijóo-Bandín S; Lago F
    Biomed Pharmacother; 2023 May; 161():114535. PubMed ID: 36931025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empagliflozin Treatment Attenuates Hepatic Steatosis by Promoting White Adipose Expansion in Obese TallyHo Mice.
    Kurtz R; Libby A; Jones BA; Myakala K; Wang X; Lee Y; Knoer G; Lo Cascio JN; McCormack M; Nguyen G; Choos END; Rodriguez O; Rosenberg AZ; Ranjit S; Albanese C; Levi M; Ecelbarger CM; Shepard BD
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.
    Kim HM; Kim YM; Huh JH; Lee ES; Kwon MH; Lee BR; Ko HJ; Chung CH
    PLoS One; 2017; 12(6):e0179204. PubMed ID: 28598982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice.
    Tahara A; Kurosaki E; Yokono M; Yamajuku D; Kihara R; Hayashizaki Y; Takasu T; Imamura M; Li Q; Tomiyama H; Kobayashi Y; Noda A; Sasamata M; Shibasaki M
    Eur J Pharmacol; 2013 Sep; 715(1-3):246-55. PubMed ID: 23707905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabeprazole mitigates obesity-induced chronic inflammation and insulin resistance associated with increased M2-type macrophage polarization.
    Li Y; Hao J; Kong X; Yuan W; Shen Y; Hui Z; Lu X
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167142. PubMed ID: 38565384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.